v3.25.2
Summary of Significant Accounting Policies (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Jun. 28, 2025
Jun. 29, 2024
Dec. 28, 2024
Dec. 30, 2023
Summary of Significant Accounting Policies [Line Items]            
Financing Receivable, Sale $ 129,100 $ 158,200 $ 254,600 $ 295,600    
Financing Receivable, Significant Sales, Transaction Fees 1,500 2,300 2,900 4,500    
Basic:            
Net income $ 12,661 $ 78,866 $ (13,499) $ 160,023    
Shares (in shares) 158,339,000 159,815,000 158,436,000 159,813,000    
Per Share (in usd per share) $ 0.08 $ 0.49 $ (0.09) $ 1.00    
Effect of dilutive securities: [Abstract]            
Add: Option shares in the money and dilutive effect of non-vested stock (in shares) 2,467,000 2,881,000 0 2,968,000    
Less: Pro forma treasury shares (in shares) (1,072,000) (991,000) 0 (976,000)    
Diluted:            
Net Income $ 12,661 $ 78,866 $ (13,499) $ 160,023    
Shares (in shares) 159,734,000 161,705,000 158,436,000 161,805,000    
Per Share (in usd per share) $ 0.08 $ 0.49 $ (0.09) $ 0.99    
Antidilutive Securities [Abstract]            
Cash and cash equivalents $ 94,577   $ 94,577   $ 75,973  
Restricted cash 27,502   27,502   37,579  
Restricted cash included in other long-term assets 96,630   96,630   103,755  
Total cash, cash equivalents and restricted cash shown in the statement of cash flows $ 218,709 $ 265,592 $ 218,709 $ 265,592 $ 217,307 $ 264,450
Stock Options            
Antidilutive Securities [Abstract]            
Antidilutive securities excluded from computation of earnings per share (in shares) 0 0 2,177,039 0    
Non Vested Stock            
Antidilutive Securities [Abstract]            
Antidilutive securities excluded from computation of earnings per share (in shares) 497,454 763,104 1,072,630 718,563